EUVIMEDEUVIMED entdecken
Crossref

Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument

Darci R Block iD, Michael A Lasho, Leslie J Donato, Jeffrey W Meeusen

American Journal of Clinical Pathology · 2024

DOI: 10.1093/ajcp/aqae040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2024. Verfasst von Darci R Block und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, US. Hauptthemen laut MEDLINE: Hemolysis, Hyperlipidemias, Jaundice. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aims of this study were to (1) establish the maximum allowable interference limits for hemolysis, lipemia, and icterus for chemistry analytes tested in body fluid samples and (2) assess the effectiveness of serial dilution to mitigate spectral interferences.

Methods

Residual body fluids from clinically ordered testing were mixed (<10% by volume) with stock solutions of interferent (spiked) and compared with a control spiked with an equal volume of 0.9% saline. The analytes were measured on the Roche cobas c501 instrument. Difference and percentage difference were calculated and compared with allowable total error limits. A subset of samples were serially diluted with 0.9% saline. Mean (SD) difference and percentage difference were calculated.

Results

The interference thresholds were lower than the package insert for lactate dehydrogenase, cholesterol, triglycerides, and total protein for hemolysis; amylase, cholesterol, and total protein for icterus; and albumin for lipemia. Only cholesterol and triglyceride results returned to baseline upon dilution of icteric samples.

Conclusions

Interference thresholds in body fluids were lower than blood for 6 analytes. Diluting interferences that surpass these limits does not produce reliable results that are comparable to the baseline results before spiking in the interferent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemolysisHyperlipidemiasJaundiceHumansBody FluidsTriglyceridesCholesterol

Stichwörter der Autor:innen

body fluidhemolysisicterusinterferenceslipemia

Substanzen

TriglyceridesCholesterol

Autor:innen und Institutionen

  • 1 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, US.

ORCID-Profile: Darci R Block

Zitieren

APA

Block, D. R., Lasho, M. A., Donato, L. J., & Meeusen, J. W. (2024). Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae040

Vancouver

Block DR, Lasho MA, Donato LJ, Meeusen JW. Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument. American Journal of Clinical Pathology. 2024. doi:10.1093/ajcp/aqae040

BibTeX
@article{Block2024,
  author = {Block, Darci R and Lasho, Michael A and Donato, Leslie J and Meeusen, Jeffrey W},
  title = {Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument},
  journal = {American Journal of Clinical Pathology},
  year = {2024},
  doi = {10.1093/ajcp/aqae040}
}
Kostenlos starten →